Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
A randomized phase II trial in 240 premenopausal women evaluated whether low-dose (Z)-endoxifen could reduce mammographic breast density with improved tolerability compared with standard tamoxifen prevention regimens.
Family Medicine/General Practice May 20th 2026
Medical News Today (MNT)
The American College of Physicians issued updated breast cancer screening guidance recommending biennial mammography for average-risk women aged 50 to 74, with shared decision-making for those 40 to 49 and discontinuation discussions after 74.
Family Medicine/General Practice May 6th 2026
Annals of Internal Medicine
ACP updated guidance recommends shared decision-making rather than routine biennial mammography for average-risk women aged 40 to 49, diverging from the USPSTF recommendation.
Family Medicine/General Practice April 28th 2026
Conexiant
Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.
Internal Medicine April 22nd 2026